MP Ventura, NE Saheb, HP Solari, VS … - Journal of Clinical Pharmacy and Therapeutics, 2005 - interscience.wiley.com Methods: The studied drugs were: Cosopt ® (5-mL bottle), Combigan ® (5-mL
bottle) and Xalacom ® (2·5-mL bottle). Five bottles of each drug were obtained
from pharmacies, and the medications lot numbers were recorded. To ... Cited by 12 - Related articles - All 4 versions
RM Feldman - eop, 2004 - Informa Pharma Science Glaucoma is one of the leading causes of irreversible blindness worldwide.
Although there is no cure for this chronic disease, medical treatment is aimed
at reducing levels of intraocular pressure (IOP) using ocular hypotensive ... Cited by 7 - Related articles - All 4 versions
AT Fung, SE Reid, MP Jones, PR Healey, PJ … - British Medical Journal, 2007 - bjo.bmj.com Results: 15 publications reporting on 14 trials (1784 participants) were
included for meta-analysis. IOP reduction favoured latanoprost (weighted mean
difference (WMD) = 1.10 mm Hg (95% confidence interval (CI) 0.57 to 1.63)). ... Cited by 5 - Related articles - BL Direct - All 5 versions
RJ Noecker - Therapeutics and Clinical Risk Management, 2006 - pubmedcentral.nih.gov In the last decade, numerous novel ocular hypotensive agents have been
introduced for the control of intraocular pressure (IOP). Clinicians now have
more options than ever in the selection of medical therapy for the ... Cited by 3 - Related articles - BL Direct - All 6 versions
S Dunker, A Schmucker, H Maier - Advances in therapy, 2007 - Springer This study was undertaken to assess tolerability, quality of life, and
persistency of use and to monitor changes in intraocular pressure (IOP) during
the first 6 mo after a switch to fixed combination latanoprost/timolol. In ... Cited by 3 - Related articles - BL Direct - All 3 versions
AJ Lee, P McCluskey, 2008 - pubmedcentral.nih.gov Lowering IOP is the most readily modifiable risk factor to delay the development
and progression of glaucoma (POAG). The fixed combination of brimonidine
tartrate 0.2% and timolol maleate 0.5% (FCBT) combines a highly selective ... Cited by 2 - Related articles - All 7 versions
JM Vinuesa-Silva, I Vinuesa-Silva, MD Pinazo- … - Archivos de la Sociedad Española de Oftalmología, 2009 - SciELO Brasil SciELO - Scientific Electronic Library Online Browse SciELO, SciELO Library
Error Detector An unexpected error occurred in SciELO servers. ... Related articles - Cached - All 5 versions
[CITATION] Tratamiento médico del glaucoma. Estado actual